State Of Wyoming Aldeyra Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $10,259 - $17,157	1,443 New	1,443 $12,000
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $2,707 - $5,402	-1,114 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.25 - $5.17 $61 - $98	19 Added 1.74%	1,114 $5,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $9.63 $63 - $173	18 Added 1.67%	1,095 $4,000
Q3 2021 Feb 11, 2022	BUY	$7.94 - $11.31 $5,121 - $7,294	645 Added 149.31%	1,077 $9,000
Q2 2021 Feb 11, 2022	BUY	$10.44 - $14.85 $4,510 - $6,415	432 New	432 $5,000

116

36.2M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $298M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.